Mark R. Dowling

Mark R. Dowling

Auto-generated profile, based on publicly available information

Mark R. Dowling

Clinical Haematology Peter MacCallum Cancer Centre and Royal Melbourne Hospital Melbourne Victoria Australia

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 February 2006 in Science
Verified
Journal Article
Closed access
PDF file
MNMichael A. Nielsen
Michael A. Nielsen
MDMark R. Dowling
Mark R. Dowling
MGMile Gu
Mile Gu
ADAndrew C. Doherty
Andrew C. Doherty
Quantum computers hold great promise for solving interesting computational problems, but it remains a challenge to find efficient quantum circuits that can perform these complicated tasks. Here we show that finding optimal quantum circuits is essentially equivalent to finding the shortest path between two points in a certain curved geometry. By recasting the problem of finding quantum circuits as a geometric problem, we open up the possibility of using the mathematical techniques of Riemannian geometry to suggest new quantum algorithms or to prove limitations on the power of quantum computers.

28 November 2014 in Science
Verified
Journal Article
Closed access
PDF file
JMJulia M. Marchingo
Julia M. Marchingo
AKAndrey Kan
Andrey Kan
RSRobyn M. Sutherland
Robyn M. Sutherland
KDKen R. Duffy
Ken R. Duffy
CWCameron J. Wellard
Cameron J. Wellard
PHPhilip D. Hodgkin
Philip D. Hodgkin
T cell responses are initiated by antigen and promoted by a range of costimulatory signals. Understanding how T cells integrate alternative signal combinations and make decisions affecting immune response strength or tolerance poses a considerable theoretical challenge. Here, we report that T cell receptor (TCR) and costimulatory signals imprint an early, cell-intrinsic, division fate, whereby cells effectively count through generations before returning automatically to a quiescent state. This autonomous program can be extended by cytokines. Signals from the TCR, costimulatory receptors, and cytokines add together using a linear division calculus, allowing the strength of a T cell response to be predicted from the sum of the underlying signal components. These data resolve a long-standing costimulation paradox and provide a quantitative paradigm for therapeutically manipulating immune response strength.

20 January 2012 in Science
Verified
Journal Article
Closed access
PDF file
KDKen R. Duffy
Ken R. Duffy
CWCameron Wellard
Cameron Wellard
JMJohn F. Markham
John F. Markham
JZJie H. S. Zhou
Jie H. S. Zhou
RHRoss Holmberg
Ross Holmberg
PHPhilip D. Hodgkin
Philip D. Hodgkin
Stochastic or Asymmetric Fate Determination?: During an adaptive immune response, B lymphocytes rapidly divide and differentiate into effector cell populations, including antibody-secreting plasmablasts and memory B cells. Many also change the class of antibody they secrete, through a process called isotype switching. During this process, some cells die. Whether cells acquire these different fates in a stochastic or programmed manner, however, is unclear. Duffy et al. (p. 338 , published online 5 January) used single-cell tracking to determine the times to division, differentiation into a plasmablast, isotype switching, and death of stimulated B lymphocytes. Statistical analysis and mathematical modeling revealed that these cell-fate decisions appear to be the result of random clocks: Which clock went off first (division, differentiation, or death), determined the fate of the cell. Barnett et al. (p. 342 , published online 15 December) sought to determine whether asymmetrical cell division, which is thought to contribute to effector cell-fate decisions in T cells, may be at work in B lymphocytes. Indeed, factors important for the initiation and maintenance of germinal center B lymphocyte identity, along with an ancestral polarity protein, were asymmetrically distributed and maintained their asymmetry during cell division.

20 March 2007 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
EHE. D. Hawkins
E. D. Hawkins
MTM. L. Turner
M. L. Turner
MDM. R. Dowling
M. R. Dowling
CGC. van Gend
C. van Gend
PHP. D. Hodgkin
P. D. Hodgkin
The magnitude of an adaptive immune response is controlled by the interplay of lymphocyte quiescence, proliferation, and apoptosis. How lymphocytes integrate receptor-mediated signals influencing these cell fates is a fundamental question for understanding this complex system. We examined how lymphocytes interleave times to divide and die to develop a mathematical model of lymphocyte growth regulation. This model provides a powerful method for fitting and analyzing fluorescent division tracking data and reveals how summing receptor-mediated kinetic changes can modify the immune response progressively from rapid tolerance induction to strong immunity. An important consequence of our results is that intrinsic variability in otherwise identical cells, usually dismissed as noise, may have evolved to be an essential feature of immune regulation.

12 September 2011 in Journal of Experimental Medicine
Verified
Journal Article
Open access
PDF file
EJEmma C. Josefsson
Emma C. Josefsson
JCJames Chloe
James Chloe
KHKatya J. Henley
Katya J. Henley
MDMarlyse A. Debrincat
Marlyse A. Debrincat
KRKelly L. Rogers
Kelly L. Rogers
BKBenjamin T. Kile
Benjamin T. Kile
It is believed that megakaryocytes undergo a specialized form of apoptosis to shed platelets. Conversely, a range of pathophysiological insults, including chemotherapy, are thought to cause thrombocytopenia by inducing the apoptotic death of megakaryocytes and their progenitors. To resolve this paradox, we generated mice with hematopoietic- or megakaryocyte-specific deletions of the essential mediators of apoptosis, Bak and Bax. We found that platelet production was unperturbed. In stark contrast, deletion of the prosurvival protein Bcl-xL resulted in megakaryocyte apoptosis and a failure of platelet shedding. This could be rescued by deletion of Bak and Bax. We examined the effect on megakaryocytes of three agents that activate the intrinsic apoptosis pathway in other cell types: etoposide, staurosporine, and the BH3 mimetic ABT-737. All three triggered mitochondrial damage, caspase activation, and cell death. Deletion of Bak and Bax rendered megakaryocytes resistant to etoposide and ABT-737. In vivo, mice with a Bak−/− Bax−/− hematopoietic system were protected against thrombocytopenia induced by the chemotherapeutic agent carboplatin. Thus, megakaryocytes do not activate the intrinsic pathway to generate platelets; rather, the opposite is true: they must restrain it to survive and progress safely through proplatelet formation and platelet shedding.

14 April 2014 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
PDF file
MDMark R. Dowling
Mark R. Dowling
AKAndrey Kan
Andrey Kan
SHSusanne Heinzel
Susanne Heinzel
JZJie H. S. Zhou
Jie H. S. Zhou
JMJulia M. Marchingo
Julia M. Marchingo
PHPhilip D. Hodgkin
Philip D. Hodgkin
Stochastic variation in cell cycle time is a consistent feature of otherwise similar cells within a growing population. Classic studies concluded that the bulk of the variation occurs in the G1 phase, and many mathematical models assume a constant time for traversing the S/G2/M phases. By direct observation of transgenic fluorescent fusion proteins that report the onset of S phase, we establish that dividing B and T lymphocytes spend a near-fixed proportion of total division time in S/G2/M phases, and this proportion is correlated between sibling cells. This result is inconsistent with models that assume independent times for consecutive phases. Instead, we propose a stretching model for dividing lymphocytes where all parts of the cell cycle are proportional to total division time. Data fitting based on a stretched cell cycle model can significantly improve estimates of cell cycle parameters drawn from DNA labeling data used to monitor immune cell dynamics. Significance Cell division is essential for an effective immune response. Estimates of rates of division are often based on DNA measurements interpreted with an appropriate model for internal cell cycle steps. Here we use time-lapse microscopy and single cell tracking of T and B lymphocytes from reporter mice to measure times spent in cell cycle phases. These data led us to a stretched cell cycle model, a novel and improved mathematical description of cell cycle progression for proliferating lymphocytes. Our model can be used to deduce cell cycle parameters for lymphocytes from DNA and BrdU labeling and will be useful when comparing the effects of different stimuli, or therapeutic treatments on immune responses, or to understand molecular pathways controlling cell division.